Tech Center 1600 • Art Units: 1653
This examiner grants 65% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17906279 | DESIGNER EXTRACELLULAR VESICLES FOR TREATING EXCITOTOXICITY | Final Rejection | OHIO STATE INNOVATION FOUNDATION |
| 16720840 | Methods and Systems for Platelet Cryopreservation | Non-Final OA | Fenwal, Inc. |
| 17816924 | C. NOVYI FOR THE TREATMENT OF SOLID TUMORS IN HUMANS | Non-Final OA | THE JOHNS HOPKINS UNIVERSITY |
| 17801959 | TISSUE CULTURE MEDIA FOR SURVIVAL AND ENGRAFTMENT OF HUMAN PANCREATIC ISLETS | Final Rejection | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 16753634 | Tissue Engineered "Axon Fusion" for Immediate Recovery Following Axon Transection | Non-Final OA | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 17521410 | IDENTIFICATION OF MICROORGANISMS USING MALDI-TOF-MS ON-PLATE EXTRACTION | Non-Final OA | BECTON DICKINSON AND COMPANY |
| 17566504 | USE OF OVARIAN-DERIVED HYDROGELS FOR RESTORATION OF REPRODUCTIVE FUNCTION AND HEALTH IN WOMEN | Non-Final OA | UPMC |
| 17789999 | FIBROCARTILAGE PREPARATION METHOD USING TENSILE STIMULATION | Final Rejection | UNIVERSITY-INDUSTRY COOPERATION GROUP OF KYUNG HEE UNIVERSITY |
| 18115402 | Wearable Engineered Human Skin and Systems and Methods for Making the Same | Non-Final OA | The Trustees of Columbia University in the City of New York |
| 17905088 | DIBORIDE MICROPATTERNED SURFACES FOR CELL CULTURE | Non-Final OA | University of Houston System |
| 18678139 | Food Materials Comprising Filamentous Fungal Particles and Membrane Bioreactor Design | Non-Final OA | The Fynder Group, Inc. |
| 18671703 | Food Materials Comprising Filamentous Fungal Particles and Membrane Bioreactor Design | Non-Final OA | The Fynder Group, Inc. |
| 17882488 | Food Materials Comprising Filamentous Fungal Particles and Membrane Bioreactor Design | Final Rejection | The Fynder Group, Inc. |
| 18063634 | CELL CULTURE BAG | Non-Final OA | NAN YA PLASTICS CORPORATION |
| 17770183 | COMPOSITIONS AND METHODS FOR ENHANCING RETINAL GANGLION CELL DEVELOPMENT AND PLURIPOTENT STEM CELL-DERIVED THREE-DIMENSIONAL TISSUE | Final Rejection | THE TRUSTEES OF INDIANA UNIVERSITY |
| 17386776 | DIFFERENTIATION-INDUCED CELL POPULATION FROM WHICH UNDIFFERENTIATED CELLS HAVE BEEN REMOVED, USE OF SAME, AND METHOD FOR PRODUCING SAME | Non-Final OA | Osaka University |
| 18624758 | METHODS AND AGRICULTURAL COMPOSITIONS FOR PREVENTING OR CONTROLLING PLANT DISEASES | Non-Final OA | Bayer CropScience LP |
| 17276267 | METHODS OF CONTROLLING ANIMAL PESTS WITH PAENIBACILLUS TERRAE | Non-Final OA | Bayer CropScience LP |
| 17055923 | STABILIZED FUNGICIDAL COMPOSITION | Final Rejection | Bayer CropScience LP |
| 18583042 | METHYLOBACTERIUM COMPOSITIONS FOR FUNGAL DISEASE CONTROL | Final Rejection | NewLeaf Symbiotics, Inc. |
| 17921802 | COMPOSITIONS AND METHODS OF PROMOTING MYELINATION | Non-Final OA | The Children's Medical Center Corporation |
| 18593295 | DEVELOPMENT OF AN ACCELERATED CELLULAR MODEL FOR EARLY CHANGES IN ALZHEIMER’S DISEASE | Non-Final OA | University of Maryland, College Park |
| 17514742 | NON-INVASIVE METHODS FOR SELECTIVELY ENRICHING PLURIPOTENT CELLS | Non-Final OA | MEMORIAL SLOAN-KETTERING CANCER CENTER |
| 18049327 | NERVE CULTURE SYSTEM | Non-Final OA | Axogen Corporation |
| 18187811 | YEAST INHIBITION WITH BACILLUS SUBTILIS VIA IRON DEPLETION | Final Rejection | Chr. Hansen A/S |
| 18286954 | COMPOSITION CONTAINING MESENCHYMAL STEM CELL AND VASCULAR ENDOTHELIAL PROGENITOR CELL AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF OCCLUSIVE VASCULAR DISEASE OR COMPLICATION THEREOF | Non-Final OA | ELPHIS CELL THERAPEUTICS |
| 18253076 | METHODS OF STABLE VITRIFICATION | Non-Final OA | UPKARA, INC. |
| 16827551 | Seed Endophytes Across Cultivars and Species, Associated Compositions, and Methods of Use Thereof | Final Rejection | Indigo Ag, Inc. |
| 18125963 | SYSTEM AND METHODS FOR SOFT-TISSUE AUGMENTATION | Non-Final OA | NuVista, LLC |
| 18044092 | Treatment of Alzheimer's Disease with Allogeneic Mesenchymal Stem Cells | Non-Final OA | Longeveron, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy